182 related articles for article (PubMed ID: 9283795)
1. The use of biothesiometry to detect neuropathy in children and adolescents with IDDM.
Davis EA; Jones TW; Walsh P; Byrne GC
Diabetes Care; 1997 Sep; 20(9):1448-53. PubMed ID: 9283795
[TBL] [Abstract][Full Text] [Related]
2. Reproducibility of vibration perception threshold values in children and adolescents with type 1 diabetes mellitus and associated factors.
Louraki M; Tsentidis C; Kallinikou D; Katsalouli M; Kanaka-Gantenbein C; Kafassi N; Papathanasiou A; Karavanaki K
Prim Care Diabetes; 2014 Jul; 8(2):147-57. PubMed ID: 24315733
[TBL] [Abstract][Full Text] [Related]
3. Comparison of vibration perception thresholds obtained with the Neurothesiometer and the CASE IV and relationship to nerve conduction studies.
Bril V; Perkins BA
Diabet Med; 2002 Aug; 19(8):661-6. PubMed ID: 12147147
[TBL] [Abstract][Full Text] [Related]
4. Long-term glycemic control and neurological function in IDDM patients.
McCance DR; Atkinson AB; Hadden DR; Kennedy L
Diabetes Care; 1993 Sep; 16(9):1291-3. PubMed ID: 8404434
[TBL] [Abstract][Full Text] [Related]
5. Distortion-product otoacoustic emissions and selective sensorineural loss in IDDM.
Di Nardo W; Ghirlanda G; Paludetti G; Cercone S; Saponara C; Del Ninno M; Di Girolamo S; Magnani P; Di Leo MA
Diabetes Care; 1998 Aug; 21(8):1317-21. PubMed ID: 9702440
[TBL] [Abstract][Full Text] [Related]
6. Strong association between vibration perception thresholds at low frequencies (4 and 8 Hz), neuropathic symptoms and diabetic foot ulcers.
Lindholm E; Löndahl M; Fagher K; Apelqvist J; Dahlin LB
PLoS One; 2019; 14(2):e0212921. PubMed ID: 30817797
[TBL] [Abstract][Full Text] [Related]
7. Childhood diabetic neuropathy: functional impairment and non-invasive screening assessment.
Blankenburg M; Kraemer N; Hirschfeld G; Krumova EK; Maier C; Hechler T; Aksu F; Magerl W; Reinehr T; Wiesel T; Zernikow B
Diabet Med; 2012 Nov; 29(11):1425-32. PubMed ID: 22507184
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of the vibration perception thresholds measurement as a diagnostic method for diabetic peripheral neuropathy: Results from the Rio de Janeiro type 2 diabetes cohort study.
Santos TRM; Melo JV; Leite NC; Salles GF; Cardoso CRL
J Diabetes Complications; 2018 Aug; 32(8):770-776. PubMed ID: 29950276
[TBL] [Abstract][Full Text] [Related]
9. Elevated vibration perception threshold in young patients with type 1 diabetes in comparison to non-diabetic children and adolescents.
Olsen BS; Nir M; Kjaer I; Vølund A; Mortensen HB
Diabet Med; 1994 Nov; 11(9):888-92. PubMed ID: 7705028
[TBL] [Abstract][Full Text] [Related]
10. Subclinical nerve dysfunction in children and adolescents with IDDM.
Hyllienmark L; Brismar T; Ludvigsson J
Diabetologia; 1995 Jun; 38(6):685-92. PubMed ID: 7672490
[TBL] [Abstract][Full Text] [Related]
11. Vibratory perception threshold in diabetic neuropathy.
Tchen PH; Chiu HC; Fu CC
J Formos Med Assoc; 1990 Jan; 89(1):23-9. PubMed ID: 1973706
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the diagnostic accuracy of Vibrasense compared to a biothesiometer and nerve conduction study for screening diabetic peripheral neuropathy.
Sharma K N S; Kumar H A
J Foot Ankle Res; 2023 Sep; 16(1):65. PubMed ID: 37770911
[TBL] [Abstract][Full Text] [Related]
13. Nerve conduction studies and vibration perception thresholds in diabetic and uremic neuropathy.
Klima RR; Weigand AH; DeLisa JA
Am J Phys Med Rehabil; 1991 Apr; 70(2):86-90. PubMed ID: 1848989
[TBL] [Abstract][Full Text] [Related]
14. Improved metabolic control using glucose monitoring systems leads to improvement in vibration perception thresholds in type 1 diabetes patients.
Dahlin LB; Elgzyri T; Löndahl M; Ekman L; Lindholm E
Acta Diabetol; 2020 Apr; 57(4):433-438. PubMed ID: 31705298
[TBL] [Abstract][Full Text] [Related]
15. Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC study.
Martin CL; Waberski BH; Pop-Busui R; Cleary PA; Catton S; Albers JW; Feldman EL; Herman WH;
Diabetes Care; 2010 Dec; 33(12):2635-41. PubMed ID: 20833868
[TBL] [Abstract][Full Text] [Related]
16. Comparison of conventional and non-invasive techniques for the early identification of diabetic neuropathy in children and adolescents with type 1 diabetes.
Nelson D; Mah JK; Adams C; Hui S; Crawford S; Darwish H; Stephure D; Pacaud D
Pediatr Diabetes; 2006 Dec; 7(6):305-10. PubMed ID: 17212597
[TBL] [Abstract][Full Text] [Related]
17. Large-fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors.
Elliott J; Tesfaye S; Chaturvedi N; Gandhi RA; Stevens LK; Emery C; Fuller JH;
Diabetes Care; 2009 Oct; 32(10):1896-900. PubMed ID: 19587366
[TBL] [Abstract][Full Text] [Related]
18. Impaired vibration perception threshold and long-term mean HbA1c in patients with type 1 diabetes mellitus.
Kullberg CE; Arnqvist HJ
Diabet Med; 1996 Dec; 13(12):1027-32. PubMed ID: 8973883
[TBL] [Abstract][Full Text] [Related]
19. The sensitivity of clinical diagnostic methods in the diagnosis of diabetic neuropathy.
Onde ME; Ozge A; Senol MG; Togrol E; Ozdag F; Saracoglu M; Misirli H
J Int Med Res; 2008; 36(1):63-70. PubMed ID: 18230269
[TBL] [Abstract][Full Text] [Related]
20. Vibration perception threshold, complaints and sensory examination in diabetic patients.
van der Naalt J; Fidler V; Oosterhuis HJ
Acta Neurol Scand; 1991 May; 83(5):297-300. PubMed ID: 2063652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
